Drug Discovery and Development

3P Biopharmaceuticals and SpyBiotech Enter Vaccine Contract Manufacturing Agreement

Looking towards completing production in 2021.

Contract Pharma Staff 10.26.20

Breaking News | Drug Development | Trials & Filings

Gilead’s Remdesivir Wins FDA Approval to Treat COVID-19

Veklury is now the first and only approved COVID-19 treatment in the U.S.

Contract Pharma Staff 10.23.20

Biologics, Proteins, Vaccines | Breaking News | Collaborations & Alliances

ABEC Delivers Process Systems to Ology Bio

Supports production of critical vaccines and therapeutics for COVID-19.

Contract Pharma Staff 10.22.20

Biologics, Proteins, Vaccines | Breaking News | Clinical Trials | Industry News

Moderna Completes Enrollment in Phase III COVID-19 Vax Study

COVE study designed in collaboration with the FDA and NIH to evaluate Americans at the highest risk of severe COVID-19 disease in 30,000 participants.

Contract Pharma Staff 10.22.20

Biologics, Proteins, Vaccines | Breaking News | Collaborations & Alliances

Kamada Signs Supply Agreement with Israeli Health Authorities

Will provide investigational Covid-19 plasma-derived Immunoglobulin.

Contract Pharma Staff 10.22.20

Breaking News | cGMP Manufacture | Drug Development | Industry News

Roche, Atea Pharma to Develop Potential Oral COVID-19 Treatment

To develop, manufacture and distribute AT-527, Atea’s investigational oral direct-acting antiviral being studied to treat COVID-19.

Contract Pharma Staff 10.22.20

ProBioGen, Heidelberg Pharma Ink ATAC Agreement

ProBioGen is conducting cell line development, process development and GMP manufacturing of the mAb intermediates of Heidelberg’s ATAC molecules for cancer.

10.22.20

Reaction Biology and 4HF Biotec Collaborate

Announce new cell-based service offering that combines their technologies.

Contract Pharma Staff 10.21.20

Biologics, Proteins, Vaccines

India Emerges as Hot Spot for Manufacturing COVID-19 Vaccines

CMOs expand and ‘repurpose’ capacities.

Online Exclusives S Harachand, Contributing Editor 10.20.20

Clinical Trials | Drug Development | Preclinical Outsourcing

Accelerating R&D Trends

The pandemic has propelled lingering trends into the forefront and increasingly complex molecules and biologics have drug developers outsourcing more.

Online Exclusives Kristin Brooks, Contract Pharma 10.20.20

APIs | Biologics, Proteins, Vaccines | Breaking News | cGMP Manufacture | Industry News

JSR Life Sciences Expands European Footprint

Will co-locate primary European operations for affiliate companies KBI Biopharma and Selexis SA in Geneva’s ZIPLO campus.

10.20.20

Breaking News | Clinical Trials

CNS Pharmaceuticals Completes U.S. Manufacturing of Berubicin

Phase 2 trial will commence during the first quarter of 2021.

Contract Pharma Staff 10.20.20

Breaking News | Clinical Trials | Collaborations & Alliances

Cytocom and Cleveland Biolabs Merge

Combine their businesses in an all-stock transaction.

Contract Pharma Staff 10.20.20

Biologics, Proteins, Vaccines | Breaking News | cGMP Manufacture | Industry News

CEVEC, Rznomics Ink License Agreement for CAP Technology

Rznomics will use CEVEC’s cell line technology with its trans-splicing ribozyme technology for manufacturing gene therapies targeting various cancers.

10.20.20

Breaking News | Clinical Trials